Targeting ALK Rearrangements in NSCLC: Current State of the Art.

Front Oncol · 2022 · PMC9020874 · PMID 35463328

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients with non-V3a/b showed a trend toward longer OS.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.